Show simple item record

Predicting mortality after kidney transplantation: a clinical tool

dc.contributor.authorJassal, Sarbjit V.en_US
dc.contributor.authorSchaubel, Douglas E.en_US
dc.contributor.authorFenton, Stanley S. A.en_US
dc.date.accessioned2010-06-01T18:42:58Z
dc.date.available2010-06-01T18:42:58Z
dc.date.issued2005-11en_US
dc.identifier.citationJassal, Sarbjit V.; Schaubel, Douglas E.; Fenton, Stanley S. A. (2005). "Predicting mortality after kidney transplantation: a clinical tool." Transplant International 18(11): 1248-1257. <http://hdl.handle.net/2027.42/71914>en_US
dc.identifier.issn0934-0874en_US
dc.identifier.issn1432-2277en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/71914
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16221155&dopt=citationen_US
dc.format.extent80832 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherMunksgaard International Publishersen_US
dc.publisherBlackwell Publishing Ltden_US
dc.rights2005 ESOTen_US
dc.subject.otherCharlson Comorbidity Indexen_US
dc.subject.otherComorbidityen_US
dc.subject.otherOutcomeen_US
dc.subject.otherPatient Survivalen_US
dc.subject.otherPrognosisen_US
dc.subject.otherRenal Transplanten_US
dc.titlePredicting mortality after kidney transplantation: a clinical toolen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationum3  Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, USAen_US
dc.contributor.affiliationother1  Department of Medicine, University of Toronto, Toronto, Canadaen_US
dc.contributor.affiliationother2  Division of Nephrology, University Health Network, Toronto, Canadaen_US
dc.identifier.pmid16221155en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/71914/1/j.1432-2277.2005.00212.x.pdf
dc.identifier.doi10.1111/j.1432-2277.2005.00212.xen_US
dc.identifier.sourceTransplant Internationalen_US
dc.identifier.citedreferenceBerthoux F, Jones E, Gellert R, Mendel S, Saker L, Briggs D. Epidemiological data of treated end-stage renal failure in the European Union (EU) during the year 1995: report of the European Renal Association Registry and the National Registries. Nephrol Dial Transplant 1999; 14: 2332.en_US
dc.identifier.citedreferenceNational Institute of Diabetes and Digestive and Kidney Diseases. U.S. Renal Data Systems, Annual Data Report (on CD). Researchers Guide, Reference Tables and ADR Slides. Ann Arbor, M.I: United States Renal Data System Coordinating Center, 2001.en_US
dc.identifier.citedreferenceCanadian Institute for Health Information 2002. CORR Preliminary Report: Preliminary Statistics on Renal Failure and Solid Organ Transplantation in Canada. Ottawa, Ontario: Canadian Institute of Health Sciences, 2002.en_US
dc.identifier.citedreferenceBeddhu S, Bruns FJ, Saul M, Seddon P, Zeidel ML. A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med 2000; 108: 609.en_US
dc.identifier.citedreferenceEiam-Ong S, Sitprija V. Comorbidities in patients with end-stage renal disease in developing countries. Artif Organs 2002; 26: 753.en_US
dc.identifier.citedreferenceKhan IH, Catto GR, Edward N, Fleming LW, Henderson IS, MacLeod AM. Influence of coexisting disease on survival on renal-replacement therapy. Lancet 1993; 341: 415.en_US
dc.identifier.citedreferenceJassal SV, Schaubel DE, Fenton SSA. Baseline comorbidity in kidney transplant recipients: a comparison of comorbidity indices. Am J Kidney Dis 2005; 46: 136.en_US
dc.identifier.citedreferenceHemmelgarn BR, Manns BJ, Quan H, Ghali WA. Adapting the Charlson comorbidity index for use in patients with ESRD. Am J Kidney Dis 2003; 42: 125.en_US
dc.identifier.citedreferenceMiskulin DC, Athienites NV, Yan G, et al. Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial. Kidney Int 2001; 60: 1498.en_US
dc.identifier.citedreferenceVan Manen JG, Korevaar JC, Dekker FW, Boeschoten EW, Bossuyt PM, Krediet RT. How to adjust for comorbidity in survival studies in ESRD patients: a comparison of different indices. Am J Kidney Dis 2002; 40: 82.en_US
dc.identifier.citedreferenceVan Manen JG, Korevaar JC, Dekker FW, Boeschoten EW, Bossuyt PM, Krediet RT. Adjustment for comorbidity in studies on health status in ESRD patients: which comorbidity index to use ? J Am Soc Nephrol 2003; 14: 478.en_US
dc.identifier.citedreferenceGaylin DS, Held PJ, Port FK, et al. The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA 1993; 269: 603.en_US
dc.identifier.citedreferenceDjukanovic L, Lezaic V, Blagojevic R, et al. Co-morbidity and kidney graft failure – two main causes of malnutrition in kidney transplant patients. Nephrol Dial Transplant 2003; 18: 68v.en_US
dc.identifier.citedreferenceCharlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373.en_US
dc.identifier.citedreference15. The organ procurement and transplantation network http://www.optn.org/data/annualReport.asp. 2004.en_US
dc.identifier.citedreferenceLoven C, Norden G, Nyberg G. Impact of cadaveric renal donor morbidity on long-term graft function. Transpl Int 2003; 16: 857.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.